Immutep IMMP
NASDAQ IMMP
$3.32 +0.09 (+2.79%)
As of: Oct 21, 2026 · 11:11 AM EDT

Immutep (IMMP) Revenue (2014 - 2017)

Updated

Immutep (IMMP) recorded Revenue of $10.33 million in the year ended Jun 30, 2026, up 56.1% from $6.62 million a year earlier.

Analysis

Immutep (IMMP) Revenue (2014 - 2017) Analysis & Trends

Starting with the year ended Jun 30, 2009, Immutep's Revenue history includes 14 years.

  • Annual Revenue has a four-year compound annual growth rate of -90.4% (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 is the highest annual Revenue since the year ended Jun 30, 2022.
  • Per Business Quant data, IMMP's Revenue was $6.62 million in the year ended Jun 30, 2025 and $122.03 billion in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 16.99 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 15.03 Bn
10 Immutep 24.17 Mn -186.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 631,151.14
Mar 31, 2017 1.31 Mn
Jun 30, 2016 178,920.35
Mar 31, 2016 260,087.26
Jun 30, 2015 130,857.36
Jun 30, 2014 14,853.75
API Access

Immutep Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IMMP&period=max&api_key=YOUR_API_KEY